Pharmaceutical Chemistry
Phase 3 – Structural Characterization Techniques
Nuclear Magnetic Resonance (NMR) Spectroscopy

Nuclear Magnetic Resonance (NMR) Spectroscopy

Introduction and Principle Nuclear magnetic resonance spectroscopy exploits the intrinsic magnetic property (spin) of certain atomic nuclei, most...

Pharmaceutical ChemistryPhase 3 – Structural Characterization Techniques4 min readUpdated 2026-07-13

Introduction and Principle

Nuclear magnetic resonance spectroscopy exploits the intrinsic magnetic property (spin) of certain atomic nuclei, most importantly hydrogen-1 and carbon-13 in organic structure elucidation, which resonate at a characteristic radiofrequency when placed within a strong external magnetic field. The precise resonance frequency of a given nucleus, expressed as its chemical shift relative to a reference standard (conventionally tetramethylsilane), is sensitively influenced by the surrounding electronic environment, allowing NMR to report directly on the local chemical environment of every distinct hydrogen and carbon atom within a molecule and thereby providing the single most information-rich structural technique available to the medicinal chemist.

1H NMR, 13C NMR, and DEPT

Proton (¹H) NMR, typically recorded at 400–600 MHz field strength, resolves the chemical shift, integration (relative proton count), multiplicity (splitting pattern arising from coupling to neighbouring protons), and coupling constant of every distinct proton environment, together providing detailed information about both the local chemical environment and the connectivity between adjacent protons. Carbon-13 (¹³C) NMR resolves the complete carbon skeleton of a molecule, though with inherently lower sensitivity than proton NMR owing to the low natural abundance of the carbon-13 isotope, typically requiring proton decoupling to simplify the resulting spectrum into a series of single resonances. The DEPT (Distortionless Enhancement by Polarisation Transfer) experiment further refines carbon-13 analysis by distinguishing carbon multiplicity directly from the spectrum: methyl and methine carbons appear as positive signals, methylene carbons appear as negative (inverted) signals, and quaternary carbons, lacking any attached proton, disappear entirely, providing immediate and unambiguous carbon-type assignment without requiring separate coupled and decoupled spectra.

Two-Dimensional NMR: COSY, HSQC, and HMBC

Two-dimensional NMR experiments correlate pairs of nuclei through their mutual coupling or spatial proximity, providing the connectivity information required for unambiguous structure elucidation of complex or novel molecules that cannot be resolved by one-dimensional spectra alone. COSY (Correlation Spectroscopy) correlates protons that are mutually coupled through, typically, two or three chemical bonds, directly revealing proton–proton connectivity across the molecular framework. HSQC (Heteronuclear Single Quantum Coherence) correlates each proton with the single carbon atom to which it is directly bonded, providing an unambiguous one-bond proton–carbon assignment map. HMBC (Heteronuclear Multiple Bond Correlation) correlates protons with carbons separated by two to three bonds, and is particularly valuable for establishing connectivity across quaternary carbons and heteroatoms that HSQC, limited to one-bond correlations, cannot directly address; the combination of COSY, HSQC, and HMBC data is typically sufficient to construct a complete, unambiguous connectivity map even for a structurally novel compound with no close literature precedent.

Why Structural Confirmation by NMR Matters

Insert appropriate diagram/illustration here

The illustration should show a representative small-molecule structure alongside its annotated COSY, HSQC, and HMBC correlation network, using arrows or dashed lines to indicate which specific proton-proton or proton-carbon pairs give rise to each correlation type, demonstrating how the three experiments together establish complete molecular connectivity.

Complete NMR characterisation of every synthesised intermediate and final compound is performed not merely as a formal record-keeping exercise but because it provides the direct, atom-level evidence that a proposed synthetic transformation has actually produced the intended structure, rather than an isomeric, rearranged, or otherwise unexpected product. From a research perspective, NMR data underlies the confident reporting of a novel synthetic method or a newly characterised structure–activity relationship; from an industrial and regulatory perspective, complete and unambiguous structural confirmation of an active pharmaceutical ingredient and its synthetic intermediates is a foundational expectation of any regulatory submission, since the safety and efficacy data generated in later development stages is only meaningful if the chemical identity of the tested compound has been rigorously confirmed.

Instrumentation, Solvents, and Interpretation Strategy

Modern NMR spectrometers operate at field strengths ranging from 300 MHz for routine structural confirmation to 600 MHz or higher for the more demanding two-dimensional experiments required for complex or novel structure elucidation, with higher field strength generally providing improved spectral resolution and sensitivity. Sample preparation requires dissolution in a deuterated solvent — commonly deuterochloroform (CDCl3) for moderately lipophilic organic compounds or deuterated dimethyl sulfoxide (DMSO-d6) for more polar or poorly chloroform-soluble compounds — chosen to avoid interference with the analyte's own proton and carbon signals. Systematic spectral interpretation typically proceeds by first assigning all readily identifiable proton and carbon signals from one-dimensional spectra, then using two-dimensional correlation data to establish connectivity between the remaining, more ambiguous signals, and finally cross-checking the fully assigned structure against the molecular formula independently established by mass spectrometry, described in the following section.

Related Topics